|
Vlassara, H; Brownlee, M; Cerami, A (1988) Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37:456-61
|
|
Vlassara, H; Valinsky, J; Brownlee, M et al. (1987) Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells. J Exp Med 166:539-49
|
|
Brownlee, M; Vlassara, H; Cerami, A (1986) Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes 35:999-1003
|
|
Vlassara, H; Spiegel, R J; San Doval, D et al. (1986) Reduced plasma lipoprotein lipase activity in patients with malignancy-associated weight loss. Horm Metab Res 18:698-703
|
|
Cerami, A; Vlassara, H; Brownlee, M (1986) Role of nonenzymatic glycosylation in atherogenesis. J Cell Biochem 30:111-20
|
|
Vlassara, H; Brownlee, M; Cerami, A (1986) Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med 164:1301-9
|
|
Vlassara, H; Brownlee, M; Cerami, A (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci U S A 82:5588-92
|
|
Brownlee, M; Vlassara, H; Cerami, A (1985) Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34:938-41
|
|
Vlassara, H; Brownlee, M; Cerami, A (1985) Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes 34:553-7
|
